EDP Biotech currently has six (6) clinical research studies on-going in the EU to support its new and improved, 2nd Generation ColoPlex™ test and upcoming launch in Europe. Hospital and Clinical Laboratory collection sites in several countries throughout the EU aim to enroll 1,200 individuals by the middle of 2018.
In addition, EDP Biotech has completed and published a US clinical research study for its 1st Generation ColoMarker assay in the Journal of Gastrointestinal Endoscopy. This research study was conducted under approved IRBs in the United States between 2010-2014. ColoPlex and ColoMarker are not cleared for clinical use in the U.S.A.
Note: All patients’ clinical status are Colonoscopy Confirmed